Alston & Bird is committed to supporting the life sciences industry’s phenomenal growth and to ensuring that leading scientific research is rapidly translated into real-world innovation and commercialization. As a firm, we have assembled a team with legal talent and scientific proficiency to address our clients’ legal needs, whether those needs relate to intellectual property procurement and enforcement, regulatory compliance, import-export issues, trade regulation, products liability and commercial litigation, public or private equity and debt financing, mergers and acquisitions, strategic alliances or other transactional matters. We possess the necessary legal skills, coupled with an understanding of the life sciences industry, to provide comprehensive legal services, solid business counseling and creative strategic thinking. We understand how the multidisciplinary aspects of the law and science must fit together.
Our client base extends across the United States to Europe, South America and Asia and includes emerging and established biotechnology companies, pharmaceutical and drug delivery companies, nationally acclaimed research centers and universities, health services organizations, medical device companies, investment banking and private equity and venture capital firms targeting life science companies.
Where Law and Science Connect ®
The diversity in our experience and technical training in areas of critical importance to life sciences companies distinguishes Alston & Bird from other law firms. Our life sciences practice includes members who collectively hold more than 30 life sciences degrees in all major fields of biology as well as in chemistry, chemical engineering and biomedical engineering, 13 of which are doctorates. We bring a depth of knowledge and expertise in a variety of fields, including pharmacology, biotechnology, genomics, proteomics, therapeutics and drug delivery, medical devices and nanotechnology, and in other chemical, agricultural and health care science areas. Our life sciences clients range from some of the largest biotechnology and pharmaceutical companies in the world to cutting-edge startup companies and also include major medical device companies and world-class research universities.
Our life sciences team members include former U.S. Senate majority leader Bob Dole; a former U.S. Representative in the House of Representatives; a former senior policy advisor for CMS; a former FDA associate commissioner for legislative affairs; and a former health policy advisor and counsel to the U.S. Senate Committee on Finance. Our team also includes a former associate general counsel for the American Red Cross, and a board member of the Southeast BIO Organization.
Bringing Value to Our Clients
The life sciences industry continues to expand exponentially. As science and technology becomes more sophisticated and complex, so do the legal challenges faced by the industry. Alston & Bird is prepared to be the law firm of choice to life sciences industry companies. Alston & Bird is Where Law and Science Connect.®
Cathy Burgess Honored as a 2021 “Health Care | Life Science Trailblazer” by The National Law Journal
Cathy Burgess, partner in Alston & Bird’s Health Care Group and leader of the firm’s FDA Compliance & Enforcement Team, has been recognized by The National Law Journal in its third annual list of professionals identified as agents of change in health care and life sciences law.
Press ReleaseJanuary 8, 2019
Brad Smyer Named a 2019 “Best Lawyer Under 40” by D Magazine
Brad Smyer, a senior associate in Alston & Bird’s Litigation & Trial Practice Group, has been named one of Dallas’s top up-and-coming lawyers by D Magazine.